# Kidney International Reports

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/kidney-international-reports/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 2,625 |
| Citations | 54,250 |
| h-index | 84 |
| Homepage | https://www.journals.elsevier.com/kidney-international-reports |
| Open Access | true |
| ISSN-L | 2468-0249 |
| ISSNs | 2468-0249 |
| OpenAlex ID | https://openalex.org/S2764478277 |
| Publisher | Elsevier BV |
| Works | 14,182 |

## Journal papers

Showing 12 of 95.

- [Outcomes for Patients With COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis](https://scholariq.org/papers/outcomes-for-patients-with-covid-19-and-acute-kidney-injury-a-systematic-review/)
- [Acute Kidney Injury Due to Collapsing Glomerulopathy Following COVID-19 Infection](https://scholariq.org/papers/acute-kidney-injury-due-to-collapsing-glomerulopathy-following-covid-19/)
- [Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria](https://scholariq.org/papers/randomized-phase-2-trial-of-telitacicept-in-patients-with-iga-nephropathy-with/)
- [COVID-19 Vaccination and Glomerulonephritis](https://scholariq.org/papers/covid-19-vaccination-and-glomerulonephritis/)
- [The Renal Pathology of Obesity](https://scholariq.org/papers/the-renal-pathology-of-obesity/)
- [DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary Glomerulonephritis](https://scholariq.org/papers/dnajb9-is-a-specific-immunohistochemical-marker-for-fibrillary/)
- [Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy](https://scholariq.org/papers/finerenone-in-predominantly-advanced-ckd-and-type-2-diabetes-with-or-without/)
- [A Systematic Review of Immune Checkpoint Inhibitor–Associated Glomerular Disease](https://scholariq.org/papers/a-systematic-review-of-immune-checkpoint-inhibitor-associated-glomerular-disease/)
- [A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis](https://scholariq.org/papers/a-phase-2-double-blind-placebo-controlled-randomized-study-of-fresolimumab-in/)
- [Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/total-kidney-volume-is-a-prognostic-biomarker-of-renal-function-decline-and/)
- [APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): Design and Rationale](https://scholariq.org/papers/apol1-long-term-kidney-transplantation-outcomes-network-apollo-design-and/)
- [Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis](https://scholariq.org/papers/combination-therapy-with-rituximab-and-cyclophosphamide-for-remission-induction/)

## Journal top topics

Showing 8 of 25.

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)
- [Renal and Vascular Pathologies](https://scholariq.org/topics/renal-and-vascular-pathologies/)
- [Organ Donation and Transplantation](https://scholariq.org/topics/organ-donation-and-transplantation/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.